[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100379219":3},{"organization":4,"armGroups":7,"interventions":25,"overallOfficials":39,"centralContacts":52,"locations":58,"responsibleParty":74,"collaborators":31,"id":76,"slug":77,"hasResults":78,"nctId":79,"briefTitle":80,"officialTitle":81,"acronym":31,"eligibilityCriteria":82,"healthyVolunteers":78,"sex":83,"minAge":84,"maxAge":31,"enrollmentInfo":85,"targetDuration":31,"studyType":88,"phases":89,"briefSummary":91,"conditions":92,"keywords":31,"overallStatus":61,"whyStopped":31,"lastUpdateSubmitDate":94,"lastUpdatePostDateStruct":95,"startDateStruct":98,"completionDateStruct":100,"leadSponsor":102,"locationsCount":103},{"fullName":5,"class":6},"Tanta University","OTHER",[8,14,20],{"label":9,"type":10,"description":11,"interventionNames":12},"Mebeverine","ACTIVE_COMPARATOR","Mebeverine 3 times daily for 3 months",[13],"Drug: Mebeverine",{"label":15,"type":16,"description":17,"interventionNames":18},"Ethosuximide","EXPERIMENTAL","Ethosuxemide 3 times daily for 3 months",[19],"Drug: ethosuximide",{"label":21,"type":16,"description":22,"interventionNames":23},"Pentoxyifylline","pentoxyifylline 2 times daily for 3 months",[24],"Drug: pentoxyifylline",[26,32,35],{"type":27,"name":28,"description":29,"armGroupLabels":30,"otherNames":31},"DRUG","pentoxyifylline","Pentoxyifylline two times daily for 3 months",[21],null,{"type":27,"name":9,"description":33,"armGroupLabels":34,"otherNames":31},"Mebeverine 3 times for 3 months",[9],{"type":27,"name":36,"description":37,"armGroupLabels":38,"otherNames":31},"ethosuximide","ethosuximide 3 times for 3 months",[15],[40,44,47,49],{"name":41,"affiliation":42,"role":43},"Mostafa Mahmoud Bahaa El dien, Msc","Clinical Pharmacy department","PRINCIPAL_INVESTIGATOR",{"name":45,"affiliation":46,"role":43},"Sahar El-Haggar, Prof","Clinical pharmacy Department- Tanta University",{"name":48,"affiliation":46,"role":43},"Sahar Hegazy, Prof.",{"name":50,"affiliation":51,"role":43},"Sherief Abd-Elsalam, Ass. Prof.","Tropical Medicine Department- Tanta University",[53],{"name":54,"role":55,"phone":56,"phoneExt":31,"email":57},"Sherief Abd-Elsalam, ass. prof.","CONTACT","00201147773440","sheriefabdelsalam@yahoo.com",[59],{"facility":60,"status":61,"city":62,"state":31,"zip":31,"country":63,"countryCode":64,"cosmosGeoPoint":65,"geoPoint":70,"contacts":71},"Sherief Abd-Elsalam","RECRUITING","Tanta","Egypt","EG",{"type":66,"coordinates":67},"Point",[68,69],31.00192,30.78847,{"lat":69,"lon":68},[72],{"name":50,"role":55,"phone":73,"phoneExt":31,"email":57},"00201009221243",{"type":43,"investigatorFullName":60,"investigatorTitle":75,"investigatorAffiliation":5,"oldNameTitle":31,"oldOrganization":31},"Ass. Prof. Tropical Medicine","100379219","phase-3-ethosuximide-and-pentoxifylline-in-the-treatment-of-abdominal-pain-related-to-irritable-bowel-syndrome-100379219",false,"NCT04217733","Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome","A Comparative Study to Assess Safety and Effectiveness of Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome","Inclusion Criteria:\n\n* • Age ≥ 18 years,\n\n  * Man and Women, Negative pregnancy test and effective contraception,\n  * IBS defined by the Rome criteria IV\n  * During the previous seven days the inclusion visit, average numeric rating scale (NRS) pain ≥ 4.\n  * IBS Treatment stable for 1 month\n\nExclusion Criteria:\n\n* • Breastfeeding\n\n  * Diabetic patients\n  * Significant liver function abnormalities (transaminases\\> 3N, cholestasis) and moderate renal disease (MDRD \\\u003C60 ml \u002F min)\n  * Addiction to alcohol and \u002F or drugs,\n  * Antiepileptic drugs taken (epilepsy or chronic pain)\n  * Chronic pain of greater intensity than that related to IBS,\n  * Known Allergyto succinimides (ethosuximide, methsuximide, phensuximide) and pentoxifylline.\n  * History or current severe depression (hospitalization, long-term antidepressant treatment)\n  * Psychotic disorders,","ALL","18 Years",{"count":86,"type":87},60,"ESTIMATED","INTERVENTIONAL",[90],"PHASE3","Ethosuximide and pentoxifylline in the treatment of abdominal pain related to irritable bowel syndrome",[93],"IBS - Irritable Bowel Syndrome","2020-01-02",{"date":96,"type":97},"2020-01-03","ACTUAL",{"date":99,"type":97},"2019-11-01",{"date":101,"type":87},"2030-12-30",{"name":5,"class":6},1]